Research and Science / Research — Rare Subtypes
Advancing Research for the Rare Melanoma Subtypes
“As a pediatric melanoma patient, I became involved with the MRF in 2016. Last March, I attended Advocacy Days to push legislation to increase research funding for the rare melanoma subtypes and policies that matter to our community. It’s so important to those of us from the rare melanoma community.”
Hosted Meeting CURE OM Global Science Meeting CURE OM catalyzed the OM research field through its innovative approach to the 13th Annual CURE OM Global Science Meeting held in the fall of 2024. Each year, CURE OM organizes this global science meeting in conjunction with the Society for Melanoma Research Congress (SMR) to foster interdisciplinary collaboration and innovation aimed at discovering effective treatments — and ultimately a cure — for OM. This year’s meeting brought together leading OM researchers and clinicians as well as patients and industry partners to discuss pivotal research, all with the shared goal of improving outcomes for patients. The scientific meeting highlighted significant advancements in ocular melanoma research while also identifying critical areas for further development. Attendees, which included researchers, clinicians and industry partners stressed the importance of ongoing collaboration, data sharing and overcoming barriers to clinical trial prioritization and advancement as well as therapy implementation and access.
— Marit Peterson Pediatric melanoma survivor and 2024 NYC Gala Courage Awardee
New Rare Subtype Grant Opportunity in 2025 The MRF will offer a new grant
opportunity — Pediatric Melanoma Established Investigator Award (EIA). This EIA will be available to established melanoma researchers or senior researchers specifically focused on advancing pediatric and adult youth adolescent (AYA) melanoma research and treatment options.
11 • Stewardship Report
Made with FlippingBook Ebook Creator